Showing results (31-40 of 114) with videos related to
Sort By:
Pageof 12
The Biochemical Journal|July 20, 2011
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteinsKimberly Romero Rosales, Gurpreet Singh, Kevin Wu, et al.Cancer Discovery|July 9, 2015
INPP4B Is a Tumor Suppressor in the Context of PTEN DeficiencyThanh-Trang T Vo, David A FrumanFrontiers in Oncology|May 1, 2023
Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemiaRoberta Buono, Muneera Alhaddad, David A FrumanMolecular Cell|June 7, 2024
The picky mTORC1 in metabolic enzyme degradationYujin Chun, David A Fruman, Gina LeeJournal of Immunology (Baltimore, Md. : 1950)|September 11, 2016
Context-Specific Function of S6K2 in Th Cell DifferentiationChristine Pai, Craig M Walsh, David A FrumanJournal of Immunology (Baltimore, Md. : 1950)|December 8, 2020
A Case for Phosphoinositide 3-Kinase-Targeted Therapy for Infectious DiseaseFolayemi Adefemi, David A Fruman, Aaron J MarshallMethods in Enzymology|October 24, 2007
Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytesAmber C Donahue, Michael G Kharas, David A FrumanBritish Journal of Clinical Pharmacology|January 26, 2016
Targeting mTOR for the treatment of B cell malignanciesJong-Hoon Scott Lee, Thanh-Trang Vo, David A FrumanJournal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytesJing Chen, Isharat Yusuf, Hilde-Marie Andersen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2013
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionSharon Lim, Tzuen Yih Saw, Min Zhang, et al.Pageof 12